Printer Friendly

CORDIS' ORION SOFT TIP ANGIOPLASTY CATHETER GAINS MARKET APPROVAL

 CORDIS' ORION SOFT TIP ANGIOPLASTY CATHETER GAINS MARKET APPROVAL
 MIAMI, July 28 /PRNewswire/ -- Cordis Corporation (NASDAQ-NMS: CORD) said today that the Food and Drug Administration has approved the U.S. market release of another of the company's angioplasty devices designed to open clogged coronary arteries: the Orion Soft Tip Steerable PTCA Balloon Catheter.
 Complementing its existing Orion intermediate tip line, Orion soft tip catheters provide interventional cardiologists a choice of tip flexibility in a fixed-wire device, a sometimes important consideration in treating certain kinds and classes of coronary lesions. The only manufacturer to offer such a choice, Cordis will begin shipping the new catheters to U.S. customers immediately. The devices are currently being sold in most foreign markets.
 Fixed-wire catheters, essentially balloons fused to guidewires, are especially low-profile devices used to treat distal or hard-to-reach lesions. Such catheters are used in some 10 percent of all coronary angioplasty procedures.
 Cordis' latest approval represents its second success on the new- product front in angioplasty in recent weeks. The company announced July 20 that the FDA had approved the U.S. release of its Sleuth PTCA Balloon Catheter, an advanced angioplasty device to compete in the 55 percent of the market made up of over-the-wire catheters.
 Miami-based Cordis Corporation manufacturers and markets a variety of medical devices and systems for the angiographic and neuroscience markets. Shares of the company's stock are traded on the NASDAQ National Market under the symbol CORD.
 -0- 7/28/92
 /CONTACT: Chick McDowell, vice president-corporate relations and assistant secretary of Cordis Corporation, 305-824-2821/
 (CORD) CO: Cordis Corporation ST: Florida IN: MTC SU:


SS-JB -- FL002 -- 3863 07/28/92 08:57 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 28, 1992
Words:275
Previous Article:AMERICAN EDUCATIONAL PRODUCTS QUARTERLY SALES SURGE 102 PCT; OPERATING PROFIT CLIMBS 103 PCT FOR FIRST 6 MONTHS, AFTER-TAX PROFITS GROW 38 PCT
Next Article:SURVEY UNCOVERS HIGH COSTS OF COMPUTER DOWNTIME; AMERICAN BUSINESSES LOSING BILLIONS
Topics:


Related Articles
CORDIS' SLEUTH ANGIOPLASTY CATHETER GAINS MARKET APPROVAL
CARDIOLOGISTS AT WASHINGTON HOSPITAL CENTER LEAD INVESTIGATION WITH INNOVATIVE LASER CATHETER
TWO NEW CORDIS ANGIOPLASTY CATHETERS GAIN U.S. MARKET RELEASE
CORDIS' SLEEK CATHETER RECEIVES "APPROVABLE LETTER"
FOUR CORDIS ANGIOPLASTY CATHETERS APPROVED FOR US MARKET RELEASE
ANOTHER CORDIS ANGIOPLASTY CATHETER APPROVED FOR US MARKET RELEASE
CORDIS PREDATOR LONG BALLOON CATHETERS APPROVED FOR U.S. MARKET RELEASE
CORDIS TRAKSTAR ANGIOPLASTY CATHETERS APPROVED FOR US MARKET RELEASE
CORDIS GAINS FDA APPROVAL FOR FOUR NEW ANGIOPLASTY CATHETERS
LOCALMED RECEIVES THIRD FDA APPROVAL FOR CORONARY DRUG DELIVERY CATHETERS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters